High-throughput platforms for machine learning-guided lipid nanoparticle design
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Lipid Membrane Structure and Behavior · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Anderson, D. G., Lynn, D. M. & Langer, R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. 42, 3153–3158 (2003).10.1002/anie.200351244 ↗
2. Breunig, M., Lungwitz, U., Liebl, R. & Goepferich, A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc. Natl Acad. Sci. USA 104, 14454–14459 (2007).10.1073/pnas.0703882104 ↗
3. Lynn, D. M. & Langer, R. Degradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc. 122, 10761–10768 (2000).10.1021/ja0015388 ↗
4. Siegwart, D. J. et al. Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc. Natl Acad. Sci. USA 108, 12996–13001 (2011).10.1073/pnas.1106379108 ↗
5. Wightman, L. et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3, 362–372 (2001).10.1002/jgm.187 ↗
6. Dahlman, J. E. et al. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat. Nanotechnol. 9, 648–655 (2014).10.1038/nnano.2014.84 ↗
7. Patra, J. K. et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol. 16, 71 (2018).10.1186/s12951-018-0392-8 ↗
8. Anselmo, A. C. & Mitragotri, S. Nanoparticles in the clinic: an update. Bioeng. Transl. Med. 4, e10143 (2019).10.1002/btm2.10143 ↗
9. Maurer, M. S. et al. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N. Engl. J. Med. 389, 1553–1565 (2023).10.1056/NEJMoa2300757 ↗
10. Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1–11 (2019).10.1016/j.omtn.2019.01.013 ↗
11. Verma, M. et al. The landscape for lipid-nanoparticle-based genomic medicines. Nat. Rev. Drug Discov. 22, 349–350 (2023).10.1038/d41573-023-00002-2 ↗
12. Dehghani-Ghahnaviyeh, S. et al. Ionizable amino lipids distribution and effects on DSPC/cholesterol membranes: implications for lipid nanoparticle structure. J. Phys. Chem. B 127, 6928–6939 (2023).10.1021/acs.jpcb.3c01296 ↗
13. McDonald, S. M. et al. Applied machine learning as a driver for polymeric biomaterials design. Nat. Commun. 14, 4838 (2023).10.1038/s41467-023-40459-8 ↗
14. Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002–1008 (2024).10.1038/s41563-024-01867-3 ↗
15. Han, X. et al. Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo. Nat. Chem. 16, 1687–1697 (2024).10.1038/s41557-024-01557-2 ↗
16. Han, X. et al. Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution. Nat. Biomed. Eng. 8, 1412–1424 (2024).10.1038/s41551-024-01267-7 ↗
17. Xue, L. et al. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nat. Nanotechnol. https://doi.org/10.1038/s41565-024-01747-6 (2024).10.1038/s41565-024-01747-6 ↗
18. Han, X. et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat. Nanotechnol. 18, 1105–1114 (2023).10.1038/s41565-023-01404-4 ↗
19. Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).10.1038/s41467-021-27493-0 ↗
20. Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat. Nanotechnol. 15, 313–320 (2020).10.1038/s41565-020-0669-6 ↗
21. Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282–300 (2023).10.1038/s41578-022-00529-7 ↗
22. Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).10.1038/s41573-020-0090-8 ↗
23. Billingsley, M. M. et al. Orthogonal design of experiments for optimization of lipid nanoparticles for mRNA engineering of CAR T cells. Nano Lett. 22, 533–542 (2022).10.1021/acs.nanolett.1c02503 ↗
24. Lokugamage, M. P. et al. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nat. Biomed. Eng. 5, 1059–1068 (2021).10.1038/s41551-021-00786-x ↗
25. Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078–1094 (2021).10.1038/s41578-021-00358-0 ↗
26. Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).10.1038/s41467-020-14527-2 ↗
27. Lokugamage, M. P., Sago, C. D. & Dahlman, J. E. Testing thousands of nanoparticles in vivo using DNA barcodes. Curr. Opin. Biomed. Eng. 7, 1–8 (2018).10.1016/j.cobme.2018.08.001 ↗
28. Zheng, L., Bandara, S. R., Tan, Z. & Leal, C. Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. Proc. Natl Acad. Sci. USA 120, e2301067120 (2023).10.1073/pnas.2301067120 ↗
29. Koltover, I., Salditt, T., Rädler, J. O. & Safinya, C. R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281, 78–81 (1998).10.1126/science.281.5373.78 ↗
30. Álvarez-Benedicto, E. et al. Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA). Biomater. Sci. 10, 549–559 (2022).10.1039/D1BM01454D ↗
31. Herrera, M., Kim, J., Eygeris, Y., Jozic, A. & Sahay, G. Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery. Biomater. Sci. 9, 4289–4300 (2021).10.1039/D0BM01947J ↗
32. Radmand, A. et al. Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart. Proc. Natl Acad. Sci. USA 121, e2307801120 (2024).10.1073/pnas.2307801120 ↗
33. Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).10.1038/mtna.2013.66 ↗
34. Gindy, M. E. et al. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery. Langmuir 30, 4613–4622 (2014).10.1021/la500630h ↗
35. Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300–7306 (2015).10.1021/acs.nanolett.5b02497 ↗
36. Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561–569 (2008).10.1038/nbt1402 ↗
37. Billingsley, M. M. et al. Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering. Nano Lett. 20, 1578–1589 (2020).10.1021/acs.nanolett.9b04246 ↗
38. Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).10.1038/ncomms5277 ↗
39. Hajj, K. A. et al. Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH. Small 15, 1805097 (2019).10.1002/smll.201805097 ↗
40. Yonezawa, S., Koide, H. & Asai, T. Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Adv. Drug Deliv. Rev. 154, 64–78 (2020).10.1016/j.addr.2020.07.022 ↗
41. Li, H. et al. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics 12, 6422–6436 (2022).10.7150/thno.77350 ↗
42. McKay, P. F. et al. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nat. Commun. 11, 3523 (2020).10.1038/s41467-020-17409-9 ↗
43. Palanki, R. et al. Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease. ACS Nano 17, 13594–13610 (2023).10.1021/acsnano.3c02268 ↗
44. Wei, T. et al. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models. Nat. Commun. 14, 7322 (2023).10.1038/s41467-023-42948-2 ↗
45. Thatte, A. S. et al. mRNA lipid nanoparticles for ex vivo engineering of immunosuppressive T cells for autoimmunity therapies. Nano Lett. 23, 10179–10188 (2023).10.1021/acs.nanolett.3c02573 ↗
46. Billingsley, M. M. et al. In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism. Small 20, 2304378 (2024).10.1002/smll.202304378 ↗
47. Love, K. T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. USA 107, 1864–1869 (2010).10.1073/pnas.0910603106 ↗
48. Forsyth, V., Rzeczycki, P., Taylor, D. & Ariosa, A. Enhancing transfection efficiency of primary immune cells through lipid nanoparticle mediated delivery. J. Immunol. 212, 0857_6526 (2024).
49. Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).10.1073/pnas.2109256118 ↗
50. Sun, Y. et al. In vivo editing of lung stem cells for durable gene correction in mice. Science 384, 1196–1202 (2024).10.1126/science.adk9428 ↗
51. Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).10.1073/pnas.2116271119 ↗
52. LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, K. A. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs. J. Control. Release 345, 819–831 (2022).10.1016/j.jconrel.2022.03.046 ↗
53. Omo-Lamai, S. et al. Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions. Adv. Mater. 36, 2312026 (2024).10.1002/adma.202312026 ↗
54. Walkey, C. D. et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8, 2439–2455 (2014).10.1021/nn406018q ↗
55. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. & Chan, W. C. W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139–2147 (2012).10.1021/ja2084338 ↗
56. Cai, R. et al. Dynamic intracellular exchange of nanomaterials’ protein corona perturbs proteostasis and remodels cell metabolism. Proc. Natl Acad. Sci. USA 119, e2200363119 (2022).10.1073/pnas.2200363119 ↗
57. Abdelkhaliq, A. et al. Impact of nanoparticle surface functionalization on the protein corona and cellular adhesion, uptake and transport. J. Nanobiotechnol. 16, 70 (2018).10.1186/s12951-018-0394-6 ↗
58. Baimanov, D. et al. In situ analysis of nanoparticle soft corona and dynamic evolution. Nat. Commun. 13, 5389 (2022).10.1038/s41467-022-33044-y ↗
59. Lee, Y. K., Choi, E.-J., Webster, T. J., Kim, S.-H. & Khang, D. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int. J. Nanomed. 10, 97–113 (2015).
60. Mahmoudi, M., Landry, M. P., Moore, A. & Coreas, R. The protein corona from nanomedicine to environmental science. Nat. Rev. Mater. 8, 422–438 (2023).10.1038/s41578-023-00552-2 ↗
61. Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).10.1038/s41467-024-50619-z ↗
62. Cheng, L. et al. Machine learning elucidates design features of plasmid deoxyribonucleic acid lipid nanoparticles for cell type-preferential transfection. ACS Nano 18, 28735–28747 (2024).10.1021/acsnano.4c07615 ↗
63. Dormán, G. The rise, fall and revival of combinatorial chemistry. Nachr. Chem. 70, 70–72 (2022).10.1002/nadc.20224127280 ↗
64. Liu, Y. et al. Ultrastiff metamaterials generated through a multilayer strategy and topology optimization. Nat. Commun. 15, 2984 (2024).10.1038/s41467-024-47089-8 ↗
65. Ha, C. S. et al. Rapid inverse design of metamaterials based on prescribed mechanical behavior through machine learning. Nat. Commun. 14, 5765 (2023).10.1038/s41467-023-40854-1 ↗
66. Coley, C. W. et al. A robotic platform for flow synthesis of organic compounds informed by AI planning. Science 365, eaax1566 (2019).10.1126/science.aax1566 ↗
67. Hashiba, K. et al. Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci. 3, 2200071 (2023).10.1002/smsc.202200071 ↗
68. Mukalel, A. J. et al. Oxidized mRNA lipid nanoparticles for in situ chimeric antigen receptor monocyte engineering. Adv. Funct. Mater. 34, 2312038 (2024).10.1002/adfm.202312038 ↗
69. Riley, R. S. et al. Ionizable lipid nanoparticles for in utero mRNA delivery. Sci. Adv. 7, eaba1028 (2021).10.1126/sciadv.aba1028 ↗
70. Chen, J. et al. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. Proc. Natl Acad. Sci. USA 120, e2309472120 (2023).10.1073/pnas.2309472120 ↗
71. Fenton, O. S. et al. Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes. Adv. Mater. 29, 1606944 (2017).10.1002/adma.201606944 ↗
72. Fenton, O. S. et al. Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery. Adv. Mater. 28, 2939–2943 (2016).10.1002/adma.201505822 ↗
73. Hatit, M. Z. C. et al. Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery. Nat. Chem. 15, 508–515 (2023).10.1038/s41557-023-01138-9 ↗
74. Da Silva Sanchez, A. J. et al. Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery. J. Control. Release 353, 270–277 (2023).10.1016/j.jconrel.2022.11.037 ↗
75. Li, Z. et al. Enzyme-catalyzed one-step synthesis of ionizable cationic lipids for lipid nanoparticle-based mRNA COVID-19 vaccines. ACS Nano 16, 18936–18950 (2022).10.1021/acsnano.2c07822 ↗
76. Jacobsen, E. N. Asymmetric catalysis of epoxide ring-opening reactions. Acc. Chem. Res. 33, 421–431 (2000).10.1021/ar960061v ↗
77. Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410–1415 (2023).10.1038/s41587-023-01679-x ↗
78. Lee, J. et al. A fully automated platform for photoinitiated RAFT polymerization. Digit. Discov. 2, 219–233 (2023).10.1039/D2DD00100D ↗
79. Götz, J. et al. High-throughput synthesis provides data for predicting molecular properties and reaction success. Sci. Adv. 9, eadj2314 (2023).10.1126/sciadv.adj2314 ↗
80. Kong, F., Yuan, L., Zheng, Y. F. & Chen, W. Automatic liquid handling for life science: a critical review of the current state of the art. SLAS Technol. 17, 169–185 (2012).10.1177/2211068211435302 ↗
81. Burger, B. et al. A mobile robotic chemist. Nature 583, 237–241 (2020).10.1038/s41586-020-2442-2 ↗
82. Dai, T. et al. Autonomous mobile robots for exploratory synthetic chemistry. Nature 635, 890–897 (2024).10.1038/s41586-024-08173-7 ↗
83. Steiner, S. et al. Organic synthesis in a modular robotic system driven by a chemical programming language. Science 363, eaav2211 (2019).10.1126/science.aav2211 ↗
84. Nambiar, A. M. K. et al. Bayesian optimization of computer-proposed multistep synthetic routes on an automated robotic flow platform. ACS Cent. Sci. 8, 825–836 (2022).10.1021/acscentsci.2c00207 ↗
85. Shields, B. J. et al. Bayesian reaction optimization as a tool for chemical synthesis. Nature 590, 89–96 (2021).10.1038/s41586-021-03213-y ↗
86. Ahneman, D. T., Estrada, J. G., Lin, S., Dreher, S. D. & Doyle, A. G. Predicting reaction performance in C–N cross-coupling using machine learning. Science 360, 186–190 (2018).10.1126/science.aar5169 ↗
87. Fromer, J. C. & Coley, C. W. An algorithmic framework for synthetic cost-aware decision making in molecular design. Nat. Comput. Sci. 4, 440–450 (2024).10.1038/s43588-024-00639-y ↗
88. Kyranos, J. N., Cai, H., Wei, D. & Goetzinger, W. K. High-throughput high-performance liquid chromatography/mass spectrometry for modern drug discovery. Curr. Opin. Biotechnol. 12, 105–111 (2001).10.1016/S0958-1669(00)00176-2 ↗
89. Ginsburg-Moraff, C. et al. Integrated and automated high-throughput purification of libraries on microscale. SLAS Technol. 27, 350–360 (2022).10.1016/j.slast.2022.08.002 ↗
90. Su, W.-C. et al. A platform method for simultaneous quantification of lipid and nucleic acid components in lipid nanoparticles. J. Chromatogr. A 1746, 465788 (2025).10.1016/j.chroma.2025.465788 ↗
91. Munjoma, N. et al. High throughput LC-MS platform for large scale screening of bioactive polar lipids in human plasma and serum. J. Proteome Res. 21, 2596–2608 (2022).10.1021/acs.jproteome.2c00297 ↗
92. Haas, C. P. et al. Open-source chromatographic data analysis for reaction optimization and screening. ACS Cent. Sci. 9, 307–317 (2023).10.1021/acscentsci.2c01042 ↗
93. Herck, J. V. et al. Operator-independent high-throughput polymerization screening based on automated inline NMR and online SEC. Digit. Discov. 1, 519–526 (2022).10.1039/D2DD00035K ↗
94. Ammini, G. D., Hooker, J. P., Herck, J. V., Kumar, A. & Junkers, T. Comprehensive high-throughput screening of photopolymerization under light intensity variation using inline NMR monitoring. Polym. Chem. 14, 2708–2716 (2023).10.1039/D3PY00190C ↗
95. Hu, G. & Qiu, M. Machine learning-assisted structure annotation of natural products based on MS and NMR data. Nat. Prod. Rep. 40, 1735–1753 (2023).10.1039/D3NP00025G ↗
96. Kulkarni, J. A. et al. On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano 12, 4787–4795 (2018).10.1021/acsnano.8b01516 ↗
97. Maeki, M. et al. Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers. PLoS ONE 12, e0187962 (2017).10.1371/journal.pone.0187962 ↗
98. Jung, H. N., Lee, S.-Y., Lee, S., Youn, H. & Im, H.-J. Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging. Theranostics 12, 7509–7531 (2022).10.7150/thno.77259 ↗
99. Strelkova Petersen, D. M., Chaudhary, N., Arral, M. L., Weiss, R. M. & Whitehead, K. A. The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism. Eur. J. Pharm. Biopharm. 192, 126–135 (2023).10.1016/j.ejpb.2023.10.006 ↗
100. Padilla, M. et al. Solution biophysics identifies lipid nanoparticle non-sphericity, polydispersity, and dependence on internal ordering for efficacious mRNA delivery. Preprint at bioRxiv https://doi.org/10.1101/2024.12.19.629496 (2025).10.1101/2024.12.19.629496 ↗